ICCVAM Agency-sponsored Workshops and Webinars

ICCVAM agencies convened workshops and webinars during 2020 and 2021, summarized in the table below, to foster collaboration and provide information about alternative testing methods. All meetings took place online.

Meeting Date and Location Sponsoring Agency (and partner organization) Meeting Title (with link to page if available) Meeting Summary
Apr 17, 2020 NIEHS NIEHS SBIR/STTR Town Hall: Development of New Approach Methodologies to Reduce Animal Use in Toxicity Testing This online town hall meeting was presented to facilitate improved communication between method developers and end-users, providing an opportunity for assay developers to hear from ICCVAM stakeholders on the desired characteristics and requirements for NAMs.
May 14, 2020 FDA Artificial Intelligence for Regulatory Science Research This presentation summarized current thinking and ongoing efforts at the FDA’s National Center for Toxicological Research in artificial intelligence, with examples from drug and food safety, natural language processing of regulatory documents, and biomarker discovery and development. The presentation also discussed guiding principles and best practices for applying artificial intelligence in regulatory science research.
Jan 22, 2020 – Nov 3, 2021 EPA (PETA Science Consortium International eV., Physicians Committee for Responsible Medicine) Webinar Series on the Use of New Approach Methodologies (NAMs) in Risk Assessment These webinars discussed computational models for acute toxicity and carcinogenicity prediction, and skin sensitization and eye irritation testing. A September 2020 event presented a proposed NAM nomination form for Toxic Substances Control Act consideration. The series will continue in 2022.
Ongoing; initiated Aug 2020 FDA Alternative Methods Webinar Series This FDA internal webinar series, organized by the FDA Alternative Methods Working Group, provides test method developers with the opportunity to introduce their new technology to FDA and give individual FDA programs the option to contact them for further information.
Feb 19, 2020 – Dec 1, 2021 FDA (Society of Toxicology) Colloquia on Emerging Toxicological Science: Challenges in Food and Ingredient Safety Since 2014, the Society of Toxicology and the FDA Center for Food Safety and Applied Nutrition have presented colloquia on high-quality, cutting-edge, future-oriented toxicological science topics. Many of the colloquia focus on alternatives to animal use. The series is continuing into 2022.
Jul 23 – Nov 12, 2020 NIEHS (PETA Science Consortium International eV., EURL ECVAM) Antibody Webinar Series Attendees learned about the applications and benefits of animal-free recombinant antibodies.
Sep 15 – 17, 2020 EPA Use of NAMs to Derive Extrapolation Factors and Evaluate Developmental Neurotoxicity for Human Health Risk Assessment This public meeting of the Federal Insecticide, Fungicide, and Rodenticide Scientific Advisory Panel considered and reviewed the use of NAMs to derive extrapolation factors and evaluate developmental neurotoxicity for human health risk assessment.
Sep 30, 2020 NIEHS, EPA (Health and Environmental Sciences Institute) Opportunities and Challenges in Using the Kinetically Derived Maximum Dose Concept to Refine Risk Assessment This symposium highlighted issues commonly raised in application of the kinetically derived maximum dose for design and interpretation of animal toxicity studies, and provided the background information needed to develop more consistent, transparent approaches to support broader application in risk assessment.
Oct 19 – 20, 2020 EPA Conference on the State of Science on Development and Use of NAMs for Chemical Safety Testing This was the second in a series of EPA conferences to highlight the state of the science on the development and use of NAMs for chemical safety testing. The next conference will be held in 2022.
May 19 – Jun 2, 2021 EPA (PETA Science Consortium International eV., Unilever, Syngenta) Inhalation Toxicity Testing These three webinars focused on using in silico and in vitro approaches for next generation risk assessment of potential respiratory toxicants.
May 26 – 27, 2021 FDA FDA Science Forum This event allowed the public to view scientific research and collaborative efforts of FDA scientists. Several topic areas focused on the application of big data and predictive toxicology to inform FDA decision-making and drive innovation.
Jun 24 – Sep 10, 2021 NIEHS Environmental Health Language Collaborative Webinars These interactive events helped set the stage, begin discussions, and draft plans for how to make progress on the Collaborative’s goals.
Sep 9, 2021 NIH Bioinformatics and Computational Biology Symposium The program for this event included a keynote presentation on “Big data for health and disease” and presentations on DNA structure, proteomic tumor analysis, data integration to study COVID-19, single-cell sequencing, and genomics.
Sep 21 – Dec 8, 2021 NIEHS (Swiss Centre for Applied Human Toxicology, Swiss State Secretariat for Economic Affairs) Current Concepts in Quantitative Risk Assessment for Skin Sensitization This webinar series provides an overview of the current state of the science in this rapidly developing field. The webinars will continue in 2022 and are intended as background for a planned workshop on quantitative risk assessment of skin sensitizing pesticides. 
Oct 25, 2021 EPA (Johns Hopkins University Center for Alternatives to Animal Testing) Challenges and Opportunities for Overcoming Dog Use in Agrochemical Evaluation and Registration At this virtual workshop, presenters reviewed the role the 90-day dog study has played in the regulation of agrochemicals in both the U.S. and Europe during the past 20 years and what approaches may be employed to substantially reduce its use.